Main Site
NIST recently released the Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile (NIST-AI-600-1). This framework was developed to assist organizations in identifying the specific […]
The Medical Device Innovation Consortium (MDIC), in partnership with Axendia, Inc. is conducting a research survey seeking to uncover the internal and external barriers medical device companies must overcome
The Good, The Bad and The Ugly In the rapidly evolving landscape of life sciences, generative AI (GEN AI) stands as a beacon of innovation,
The State of Generative AI In Life Sciences: New Market Research Read More »
How Will It Affect You? The FDA has released a paper through its medical product centers to reaffirm its commitment to the responsible and ethical
FDA on Artificial Intelligence Across the Product Lifecycle Read More »
Axendia’s 2024 Life Sciences Industry Radar Axendia unveiled its fifth annual Life Science Industry Radar on February 15, 2024, during a live “Straight from the Source”
Plotting a Course to Success in the Age of Price Negotiations Read More »
An Axendia Voice of The Customer Report The need for clinical evidence on medical devices is steadily increasing – for regulatory submissions, postmarket surveillance, reimbursement,
Developing Med Tech Clinical Evidence: Challenges and New Approaches Read More »
An Axendia Market Readiness Assessment Report While most biopharma companies have complex stage-gate product development, change management and investigation processes, they lack the ability to
Accelerating Time To Market with Biopharma PLM Read More »
Research Report This report highlights how life-sciences companies are reimagining the way they operate by leveraging advanced manufacturing technologies. We think you’ll find the results
The Needle is Moving: Digital Transformation in Life Sciences Manufacturing Read More »
